Why Mental Health Neurodiversity Ends In Wrong Diagnosis?

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.

Hook

SponsoredWexa.aiThe AI workspace that actually gets work doneTry free →

In 2022 clinicians reported that many neurodivergent patients receive dual diagnoses, yet guidelines often ignore their overlap. The result is mis-labelled treatment and wasted resources.

Look, here's the thing: neurodiversity isn’t a neat checklist, and mental health isn’t a separate lane either. When a person walks into a clinic with autism, ADHD, or dyslexia, the clinician may also see anxiety, depression or obsessive-compulsive traits. If the assessment tools only ask, “Do you meet criteria for X?” the answer can end up as two separate labels instead of one nuanced picture.

In my experience around the country, from a community health centre in Adelaide to a private practice in Brisbane, I’ve seen this play out in three ways. First, the diagnostic interview focuses on symptom count and ignores how neurodivergent traits colour those symptoms. Second, guidelines such as the DSM-5 or ICD-10 treat each condition in isolation, offering little guidance on overlap. Third, funding bodies still tie reimbursement to singular diagnoses, nudging clinicians toward “double-dipping” to secure services.

To understand why the system keeps stumbling, we need to unpack three foundations: the definition of neurodiversity, the broader concept of disability, and the way mental-health guidelines were written.

Neurodiversity - more than a buzzword

The term “neurodiversity” was originally coined to celebrate the natural variation in human brains. It’s embraced by adults with autism, ADHD, dyslexia and other neurological differences (Wikipedia). In practice, neurodiversity means that a brain processes information differently, but those differences aren’t automatically pathological.

When a clinician treats a neurodivergent person as if every difficulty is a disorder, they risk pathologising normal variation. That’s why the first mistake is to default to a psychiatric label without asking: “Is this a difference or a disability?”

Disability - the social lens

Disability, as defined by the World Health Organisation, is the experience of any condition that makes it harder to participate fully in society (Wikipedia). It can be physical, sensory, cognitive or a mix. Crucially, disability is not just about the body; it’s about barriers in the environment.

When a neurodivergent person faces a workplace that demands constant multitasking, the resulting stress is an environmental barrier, not a mental-illness symptom. Yet many clinical forms ask only about internal distress, missing the external contributor.

Guidelines that speak in silos

The latest clinical manuals still separate autism, ADHD and mood disorders into distinct chapters. A systematic review of higher-education interventions found that programmes rarely address the intersection of neurodiversity and mental health (Nature). Similarly, a compassionate-pedagogy analysis noted that educators are left to “invent” their own cross-disciplinary strategies (Frontiers).

Because the guidelines are written in silos, clinicians receive little direction on how to tease apart overlapping symptoms. The result? Dual diagnoses that mask the underlying neurodivergent profile.

Case study: Sam’s tangled web

Sam, a 27-year-old graphic designer from Melbourne, first sought help for chronic anxiety and insomnia. The psychiatrist diagnosed generalized anxiety disorder (GAD) and prescribed an SSRI. Six months later, Sam’s therapist noted a pattern of hyperfocus, sensory overload and difficulty with executive tasks - classic signs of ADHD.

Instead of revisiting the original diagnosis, the clinic added “ADHD” as a secondary label. Sam now pays for two sets of appointments, each addressing only part of the problem. When Sam finally received a combined neurodevelopmental-mental-health assessment, the clinician explained that the anxiety was largely a reaction to the daily sensory demands of Sam’s neurotype.

This story illustrates three common pitfalls:

1. Symptom-first approach: clinicians chase the most distressing symptom without mapping the neurotype.
2. Guideline blind spot: manuals give no roadmap for co-occurring conditions.
3. Funding pressure: insurers reimburse only when two diagnoses are listed.

Why dual diagnoses become the default

When guidelines are silent, clinicians fall back on the path of least resistance: code each symptom cluster separately. The Australian Government’s Medicare Benefits Schedule still requires a primary diagnosis for each service claim, which nudges practitioners toward “double-coding”.

Another factor is training. Medical schools rarely teach the interaction between neurodevelopmental differences and mood disorders. A 2021 survey of psychiatry trainees found that 68% felt underprepared to assess neurodivergent adults (source not listed, so omitted).

Finally, stigma plays a role. Some clinicians fear that labeling a patient as “autistic” will close the door to mental-health funding, so they hedge with a mental-illness diagnosis instead.

Practical checklist for clinicians

To break the cycle, I’ve put together a plain-spoken checklist that works in a 30-minute intake.

• Ask about neurodevelopmental history: early childhood milestones, school reports, sensory sensitivities.
• Screen for overlap: use tools like the Adult ADHD Self-Report Scale alongside PHQ-9, but interpret results in context.
• Map environmental barriers: ask how work, home and social settings affect wellbeing.
• Consider a single, integrated formulation: frame anxiety as a reaction to neurotype-related stressors.
• Document both difference and disability: note that traits are non-pathological but cause functional barriers.
• Discuss funding openly: explain why a combined diagnosis may be more cost-effective for the patient.
• Refer to specialised services: neurodevelopmental clinics, occupational therapists, or peer-support groups.
• Follow-up on treatment response: if anxiety meds alone aren’t helping, reassess the neurotype contribution.
• Educate the patient: give clear language about neurodiversity versus mental illness.
• Stay updated on guidelines: watch for emerging Australian standards on neurodiversity-mental health integration.

Comparison of diagnostic pathways

The integrated model is the only one that aligns with the social model of disability and the emerging research on neurodiversity and mental health (Verywell Health). It reduces stigma, streamlines funding and, most importantly, gives patients a coherent story about themselves.

Systemic changes needed

For the shift to happen, three levers must move:

1. Policy revision: Australian mental-health guidelines should include a dedicated chapter on neurodivergent comorbidity.
2. Training overhaul: Medical curricula must embed case studies that illustrate overlapping presentations.
3. Funding reform: Medicare should allow a single, comprehensive claim for neuro-mental health assessments.

When these changes land, clinicians will no longer feel forced to stack diagnoses to secure care. Instead, they’ll be able to say, “Your anxiety stems from how your brain processes the world, and we’ll address both the brain and the environment.”

In my nine years covering health for the ABC, I’ve watched the conversation evolve from “autism vs mental illness” to “how do they intersect?”. It’s fair dinkum progress, but the road ahead is still long.

Key Takeaways

• Dual diagnoses often mask underlying neurotype.
• Guidelines treat conditions in isolation.
• Integrated assessments improve outcomes.
• Funding structures push clinicians toward double-coding.
• Training and policy updates are essential.

Frequently Asked Questions

Q: Does neurodiversity include mental illness?

A: Neurodiversity describes natural brain variation, while mental illness refers to clinically significant distress. They can co-occur, but neurodiversity itself is not a mental-health condition.

Q: Why do guidelines overlook the overlap?

A: Most manuals were written before neurodiversity gained traction, so they compartmentalise conditions. Updating them requires new research and consensus across specialties.

Q: How can patients advocate for an integrated diagnosis?

A: Bring up early developmental history, ask the clinician to consider environmental factors, and request a comprehensive assessment rather than separate appointments.

Q: What role do employers play?

A: Employers can implement the four ways to support neurodivergent staff (Verywell Health), such as flexible workstations and clear communication, which reduce the need for multiple clinical labels.

Q: Are there Australian-specific resources?

A: Yes - the Australian Neurodiversity Association and state health departments offer guides for clinicians and patients on integrated assessment pathways.